Norges Bank’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $126M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $146M | Sell |
|
|||||
|
2024
Q1 | $125M | Buy |
|
|||||
|
2023
Q4 | $80.7M | Buy |
|
|||||
|
2023
Q3 | $98.5M | Sell |
|
|||||
|
2023
Q2 | $95.1M | Buy |
|
|||||
|
2023
Q1 | $106M | Sell |
|
|||||
|
2022
Q4 | $112M | Buy |
|
|||||
|
2022
Q3 | $92.4M | Buy |
|
|||||
|
2022
Q2 | $55.9M | Buy |
|
|||||
|
2022
Q1 | $53.8M | Buy |
|
|||||
|
2021
Q4 | $59M | Buy |
|
|||||
|
2021
Q3 | $58.8M | Sell |
|
|||||
|
2021
Q2 | $51.3M | Sell |
|
|||||
|
2021
Q1 | $50.2M | Buy |
|
|||||
|
2020
Q4 | $79.7M | Sell |
|
|||||
|
2020
Q3 | $70.1M | Sell |
|
|||||
|
2020
Q2 | $90.1M | Sell |
|
|||||
|
2020
Q1 | $56.4M | Hold |
|
|||||
|
2019
Q4 | $74.3M | Buy |
|
|||||
|
2019
Q3 | $37.7M | Buy |
|
|||||
|
2019
Q2 | $73.9M | Sell |
|
|||||
|
2019
Q1 | $66.2M | Buy |
|
|||||
|
2018
Q4 | $57.9M | Buy |
|
|||||
|
2018
Q3 | $73.3M | Buy |
|
|||||
|
2018
Q2 | $53.9M | Sell |
|
|||||
|
2018
Q1 | $34.6M | Sell |
|
|||||
|
2017
Q4 | $27.2M | Sell |
|
|||||
|
2017
Q3 | $26.9M | Buy |
|
|||||
|
2017
Q2 | $19.3M | Hold |
|
|||||
|
2017
Q1 | $17M | Buy |
|
|||||
|
2016
Q4 | $11.2M | Buy |
|
|||||
|
2016
Q3 | $20M | Buy |
|
|||||
|
2016
Q2 | $2.18M | Buy |
|